You are now leaving GSK Malta Health Portal

You are about to leave a GSK Website. By clicking this link, you will be taken to an external website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on this site. If you do not wish to leave this website, click on “Go Back” below:

Continue

Go back

MLT_GIB/OTH/0007/17m
Date of preparation: March 2018

Product overview

Augmentin (amoxicillin-clavulanate) is indicated for short-term treatment of bacterial infections caused by susceptible organisms.

 

 

Augmentin is a registered trademark of the GlaxoSmithKline Group of Companies